Evidence map›Paper›PMID 29483288›Full record

ArticleInfection and immunity2018

Human Interleukin-32γ Plays a Protective Role in an Experimental Model of Visceral Leishmaniasis in Mice.

Rodrigo Saar Gomes, Muriel Vilela Teodoro Silva, Jéssica Cristina Dos Santos, Christine van Linge, Juliana Machado Reis, Mauro Martins Teixeira, Sebastião Alves Pinto, Miriam Leandro Dorta, Xiyuan Bai, Edward D Chan and 4 more

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Infection and immunity, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Interleukin-32Journal of immunology research · 2022
    Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 3 countries.

Rodrigo Saar GomesInstituto de Patologia Tropical e Saúde Pública, Universidade Federal de Goiás, Goiânia, Brazil.
Muriel Vilela Teodoro SilvaInstituto de Patologia Tropical e Saúde Pública, Universidade Federal de Goiás, Goiânia, Brazil.
Jéssica Cristina Dos SantosInstituto de Patologia Tropical e Saúde Pública, Universidade Federal de Goiás, Goiânia, Brazil.
Christine van LingeInstituto de Patologia Tropical e Saúde Pública, Universidade Federal de Goiás, Goiânia, Brazil.
Juliana Machado ReisInstituto de Patologia Tropical e Saúde Pública, Universidade Federal de Goiás, Goiânia, Brazil.
Mauro Martins TeixeiraDepartamento de Bioquímica e Imunologia, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
Sebastião Alves PintoFaculdade de Medicina, Universidade Federal de Goiás, Goiânia, Brazil.
Miriam Leandro DortaInstituto de Patologia Tropical e Saúde Pública, Universidade Federal de Goiás, Goiânia, Brazil.
Xiyuan BaiSchool of Medicine, Division of Infectious Diseases, University of Colorado Denver, Aurora, Colorado, USA.
Edward D ChanSchool of Medicine, Division of Infectious Diseases, University of Colorado Denver, Aurora, Colorado, USA.
Charles A DinarelloSchool of Medicine, Division of Infectious Diseases, University of Colorado Denver, Aurora, Colorado, USA.
Milton Adriano Pelli OliveiraInstituto de Patologia Tropical e Saúde Pública, Universidade Federal de Goiás, Goiânia, Brazil.
Leo A B Joosten *Instituto de Patologia Tropical e Saúde Pública, Universidade Federal de Goiás, Goiânia, Brazil.
Fátima Ribeiro-Dias *Instituto de Patologia Tropical e Saúde Pública, Universidade Federal de Goiás, Goiânia, Brazil fatimardias@gmail.com.
Universidade Federal de Goiás · BRUniversity of Colorado Denver · USRadboud University Nijmegen · NLUniversidade Federal de Minas Gerais · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Visceral leishmaniasis (VL) is a chronic parasitic disease caused by

Indexed as

Protective FactorsAnimalsHumansImmunity, InnateInterleukinsLeishmania infantumLeishmaniasis, VisceralMiceMice, Inbred BALB CMice, TransgenicModels, AnimalIL32 protein, humanInterleukinscytokinesinterleukin-32Leishmania infantumnitric oxidevisceral leishmaniasis

Identifiers

PMID29483288
PMCPMC5913854
OpenAlexW2787951277

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.